|
Market Closed -
Xetra
18:35:49 04/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 189.92 EUR | +3.77% |
|
+1.06% | +26.66% |
| 09-04 | Eisai, Biogen Secure China's Nod for Self-Injection Version of Leqembi | MT |
| 09-03 | Piper Sander Adjusts Biogen Price Target to $245 From $225, Maintains Overweight Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOGEN INC. | Biopharmaceuticals | +3.77% | +1.06% | +26.66% | +56.31% | -33.26% | 32.63B |
-
|
-
|
-
|
- Stock Market
- Stocks
- BIIB Stock
- IDP Stock
- Charts Biogen Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
